These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
102 related articles for article (PubMed ID: 9873707)
1. Fluorescent probes for adenosine receptors: synthesis and biology of N6-dansylaminoalkyl-substituted NECA derivatives. Macchia M; Salvetti F; Barontini S; Calvani F; Gesi M; Hamdan M; Lucacchini A; Pellegrini A; Soldani P; Martini C Bioorg Med Chem Lett; 1998 Nov; 8(22):3223-8. PubMed ID: 9873707 [TBL] [Abstract][Full Text] [Related]
2. 7-Nitrobenzofurazan (NBD) derivatives of 5'-N-ethylcarboxamidoadenosine (NECA) as new fluorescent probes for human A(3) adenosine receptors. Macchia M; Salvetti F; Bertini S; Di Bussolo V; Gattuso L; Gesi M; Hamdan M; Klotz KN; Laragione T; Lucacchini A; Minutolo F; Nencetti S; Papi C; Tuscano D; Martini C Bioorg Med Chem Lett; 2001 Dec; 11(23):3023-6. PubMed ID: 11714602 [TBL] [Abstract][Full Text] [Related]
3. Synthesis and biological activity of a new series of N6-arylcarbamoyl, 2-(Ar)alkynyl-N6-arylcarbamoyl, and N6-carboxamido derivatives of adenosine-5'-N-ethyluronamide as A1 and A3 adenosine receptor agonists. Baraldi PG; Cacciari B; Pineda de Las Infantas MJ; Romagnoli R; Spalluto G; Volpini R; Costanzi S; Vittori S; Cristalli G; Melman N; Park KS; Ji XD; Jacobson KA J Med Chem; 1998 Aug; 41(17):3174-85. PubMed ID: 9703463 [TBL] [Abstract][Full Text] [Related]
4. 2-Substituted N-ethylcarboxamidoadenosine derivatives as high-affinity agonists at human A3 adenosine receptors. Klotz KN; Camaioni E; Volpini R; Kachler S; Vittori S; Cristalli G Naunyn Schmiedebergs Arch Pharmacol; 1999 Aug; 360(2):103-8. PubMed ID: 10494877 [TBL] [Abstract][Full Text] [Related]
5. 4-[6-(Dansylamino)hexylamino]-7-methyl-2-phenyl-1,8-naphthyridine as a new potential fluorescent probe for studying A1-adenosine receptor. Macchia M; Bertini S; Di Bussolo V; Manera C; Martini C; Minutolo F; Mori C; Saccomanni G; Tuscano D; Ferrarini PL Farmaco; 2002 Oct; 57(10):783-6. PubMed ID: 12420873 [TBL] [Abstract][Full Text] [Related]
7. A functional screening of adenosine analogues at the adenosine A2B receptor: a search for potent agonists. de Zwart M; Link R; von Frijtag Drabbe Künzel JK; Cristalli G; Jacobson KA; Townsend-Nicholson A; IJzerman AP Nucleosides Nucleotides; 1998 Jun; 17(6):969-85. PubMed ID: 9708319 [TBL] [Abstract][Full Text] [Related]
8. Comparative pharmacology of human adenosine receptor subtypes - characterization of stably transfected receptors in CHO cells. Klotz KN; Hessling J; Hegler J; Owman C; Kull B; Fredholm BB; Lohse MJ Naunyn Schmiedebergs Arch Pharmacol; 1998 Jan; 357(1):1-9. PubMed ID: 9459566 [TBL] [Abstract][Full Text] [Related]
9. Humoral effects of selective adenosine agonists in spontaneously hypertensive rats. Sala C; Monopoli A; Alberti C; Casati C; Ongini E; Zanchetti A; Morganti A J Hypertens; 1996 Jan; 14(1):75-9. PubMed ID: 12013498 [TBL] [Abstract][Full Text] [Related]
10. 2-alkenyl and 2-alkyl derivatives of adenosine and adenosine-5'-N-ethyluronamide: different affinity and selectivity of E- and Z-diastereomers at A2A adenosine receptors. Vittori S; Camaioni E; Di Francesco E; Volpini R; Monopoli A; Dionisotti S; Ongini E; Cristalli G J Med Chem; 1996 Oct; 39(21):4211-7. PubMed ID: 8863798 [TBL] [Abstract][Full Text] [Related]
11. Characterization of a low affinity binding site for N6-substituted adenosine derivatives in rat testis membranes. Mazzoni MR; Buffoni RS; Giusti L; Lucacchini A J Recept Signal Transduct Res; 1995; 15(7-8):905-29. PubMed ID: 8673723 [TBL] [Abstract][Full Text] [Related]
12. Identification and functional characterization of A1 and A2 adenosine receptors in the rat vas deferens: a comparison with A1 receptors in guinea pig left atrium and A2 receptors in guinea pig aorta. Martin PL; May JM J Pharmacol Exp Ther; 1994 Jun; 269(3):1228-35. PubMed ID: 8014866 [TBL] [Abstract][Full Text] [Related]
13. Influence of fluorophore and linker composition on the pharmacology of fluorescent adenosine A1 receptor ligands. Baker JG; Middleton R; Adams L; May LT; Briddon SJ; Kellam B; Hill SJ Br J Pharmacol; 2010 Feb; 159(4):772-86. PubMed ID: 20105183 [TBL] [Abstract][Full Text] [Related]
14. 2-Alkynyl derivatives of adenosine-5'-N-ethyluronamide: selective A2 adenosine receptor agonists with potent inhibitory activity on platelet aggregation. Cristalli G; Volpini R; Vittori S; Camaioni E; Monopoli A; Conti A; Dionisotti S; Zocchi C; Ongini E J Med Chem; 1994 May; 37(11):1720-6. PubMed ID: 8201607 [TBL] [Abstract][Full Text] [Related]
16. Comparison of different microscopy approaches to quantification of inhibitory effect on thrombus formation under flow conditions by the example of adenosine receptor agonist HE-NECA. Przygodzki T; Wolska N; Talar M; Polak D; Gapinska M; Watala C J Pharmacol Toxicol Methods; 2018; 94(Pt 1):94-104. PubMed ID: 30031827 [TBL] [Abstract][Full Text] [Related]
17. Synthesis of carbocyclic analogues of MECA and NECA 1,2-disubstituted as potential adenosine receptor agonists. Besada P; González-Moa MJ; Terán C; Teijeira M; Santana L Nucleosides Nucleotides Nucleic Acids; 2003; 22(5-8):759-61. PubMed ID: 14565272 [TBL] [Abstract][Full Text] [Related]
19. Pharmacological characterization of adenosine A2B receptors: studies in human mast cells co-expressing A2A and A2B adenosine receptor subtypes. Feoktistov I; Biaggioni I Biochem Pharmacol; 1998 Mar; 55(5):627-33. PubMed ID: 9515573 [TBL] [Abstract][Full Text] [Related]
20. Characterization of the A2 adenosine receptor labeled by [3H]NECA in rat striatal membranes. Bruns RF; Lu GH; Pugsley TA Mol Pharmacol; 1986 Apr; 29(4):331-46. PubMed ID: 3010074 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]